{
    "code": "01057819",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01057819",
    "time": "2017-05-05 03:04:28",
    "許可證字號": "衛署藥製字第057819號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/01\/25",
    "發證日期": "102\/01\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105781903",
    "中文品名": "可諾通&quot;艾威群&quot;膜衣錠75毫克",
    "英文品名": "Clopidogrel &quot;Alvogen&quot; F.C. tablets 75mg",
    "適應症": "降低近期發生中風、心肌梗塞或周邊動脈血管疾病的粥狀動脈硬化病人之粥狀動脈栓塞事件(如:心肌梗塞、中風或其他因血管病變引起的死亡)的發生。與ASPIRIN併用降低非ST段上升之急性冠心症(不穩定性心絞痛和非Q波型心肌梗塞)病人(包括經皮冠狀動脈介入性治療後放置支架的患者)之粥狀動脈栓塞事件。與ASPIRIN併用可用於以內科治療的ST段上升之急性心肌梗塞病人。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000粒PTP 鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "CLOPIDOGRELHYDROGENSULFATE"
    ],
    "限制項目": "01國　產 24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "6401100487  台灣艾威群股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1112209300  培力藥品工業股份有限公司",
        "製造廠廠址": "台中市西屯區工業區六路11號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012600210",
            "成分名稱": "CLOPIDOGREL HYDROGEN SULFATE",
            "含量描述": "(equ. to Clopidogrel 75mg)",
            "含量": "97.8750000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單-104-12-21(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057819&Seq=005&Type=9"
        },
        {
            "title": "057819-104-10-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057819&Seq=007&Type=8"
        }
    ]
}